This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Toronto directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $200,000
Evaluating Novel Approaches that enGage And support vulnerable patient Groups to Equitably access primary care (ENGAGE): Building the foundation for a national adaptive platform trial
CIHR · 2023 · Co-investigator
- $100,000
Adaptive platform trials in pandemics: Evaluating COVID-19 case studies and developing guidelines for future health emergencies
CIHR · 2023 · Co-investigator
- $883,029
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-Acquired Pneumonia (REMAP-CAP): Enshrining a Global Pandemic Research Response to COVID-19 and Beyond
CIHR · 2022 · Principal investigator
Evaluating Novel Approaches that enGage And support vulnerable patient Groups to Equitably access primary care (ENGAGE): Building the foundation for a national adaptive platform trial
Principal investigators: Pinto, Andrew D; Martin, Danielle; Green, Michael E; Hosseini, Benita; Zsager, Alexander
Keywords: Access To Care; Adaptive Platform Trial; Cluster Randomized Controlled Trial; Health Equity; Primary Care; Primary Health Care; Social Determinants Of Health; Vulnerable Populations
Adaptive platform trials in pandemics: Evaluating COVID-19 case studies and developing guidelines for future health emergencies
Principal investigators: Hosseini, Benita; Pinto, Andrew D
Keywords: Adaptive Platform Trials (Apts); Comparative Case Study; Guidelines Development; Pandemic Preparedness
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-Acquired Pneumonia (REMAP-CAP): Enshrining a Global Pandemic Research Response to COVID-19 and Beyond
Principal investigators: Marshall, John C; Dalziel, Sandra; Kho, Michelle E; Lamontagne, Francois; Leligdowicz, Aleksandra; Murthy, Srinivas; Park, Jay; Smith, Kathleen F
Keywords: Acute Organ Dysfunction; Covid-19; Critical Illness; Global Health; Hemodynamic Management; Platform Trial; Research Collaboration; Ventilatory Support
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna
Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial
Canadian ADAptive Platform Trial of COVID-19 Therapeutics in Community Settings (Can-ADAPT COVID)
Principal investigators: Pinto, Andrew D; Keynan, Yoav; Greiver, Michelle; Jüni, Peter; Lee, Todd C; McDonald, Emily G; Murthy, Srinivas; Selby, Peter L
Keywords: Adaptive Platform Trial; Covid-19; Nirmatrelvir; Out-Patient; Sars-Cov-2; Therapeutics
The Randomized Embedded Multifactorial Adaptive Platform Trial in Community-Acquired Pneumonia (REMAP-CAP): Enshrining a Global Pandemic Research Response to COVID-19 and Beyond
Principal investigators: Marshall, John C; Dalziel, Sandra; Kho, Michelle E; Lamontagne, Francois; Leligdowicz, Aleksandra; Murthy, Srinivas; Park, Jay; Smith, Kathleen F
Keywords: Acute Organ Dysfunction; Covid-19; Critical Illness; Global Health; Hemodynamic Management; Platform Trial; Research Collaboration; Ventilatory Support
Canadian ADAptive Platform Trial of COVID-19 Therapeutics in Community Settings (Can-ADAPT COVID)
Principal investigators: Pinto, Andrew D; Keynan, Yoav; Greiver, Michelle; Jüni, Peter; Lee, Todd C; McDonald, Emily G; Murthy, Srinivas; Selby, Peter L
Keywords: Adaptive Platform Trial; Covid-19; Nirmatrelvir; Out-Patient; Sars-Cov-2; Therapeutics
BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Principal investigators: Daneman, Nick; Murthy, Srinivas; Yamamura, Deborah L; Fowler, Robert A; Johnstone, Jennie; Lee, Todd C; MacFadden, Derek R; McDonald, Emily G; Paterson, David L; Rogers, Benjamin A; Yahav, Dafna
Keywords: Adaptive Platform Trial; Antibiotic De-Escalation; Antibiotic Step-Down; Antimicrobial Resistance; Bloodstream Infection; Central Venous Catheter Infection; Gram Negative Bacteremia; Randomized Controlled Trial
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.